Methylenedioxytrimethylamphetamine
| Clinical data | |
|---|---|
| Other names | 3,4-Methylenedioxy-N,N,N-trimethylamphetamine; MDTMA; Methylenedioxytrimethylamphetamine; N,N,N-Trimethyl-MDA |
| ATC code |
|
| Chemical and physical data | |
| Formula | C13H20NO2+ |
| Molar mass | 222.308 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3,4-Methylenedioxy-N,N,N-trimethylamphetamine (MDTMA), also known as N,N,N-trimethyl-MDA, is a chemical compound of the amphetamine and methylenedioxyamphetamine families.[1] In contrast to 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-methylamphetamine (MDMA), and 3,4-methylenedioxy-N,N-dimethylamphetamine (MDDMA), MDTMA is completely inactive as a monoamine releasing agent.[1]
See also
- Substituted methylenedioxyphenethylamine
- MDDM (N,N-dimethyl-MDA)
- Dimethylone (βk-MDDM; N,N-dimethyl-MDC)
References
- ^ a b Sandtner W, Stockner T, Hasenhuetl PS, Partilla JS, Seddik A, Zhang YW, Cao J, Holy M, Steinkellner T, Rudnick G, Baumann MH, Ecker GF, Newman AH, Sitte HH (January 2016). "Binding Mode Selection Determines the Action of Ecstasy Homologs at Monoamine Transporters". Mol Pharmacol. 89 (1): 165–175. doi:10.1124/mol.115.101394. PMC 4702095. PMID 26519222.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.